• MG-262 (Z-Leu-Leu-Leu-B(OH)2): Precision Proteasome Inhibiti

  2026-05-19

  Explore the advanced applications of MG-262 (Z-Leu-Leu-Leu-B(OH)2) in dissecting proteasome function and muscle protein homeostasis. This article uniquely connects proteasome inhibition to chaperone-mediated autophagy and age-related muscle decline, offering actionable insights for apoptosis research and cell cycle arrest studies.

• GSK-923295 and the Centromere: Precision CENP-E Inhibition i

  2026-05-18

  Explore how GSK-923295, a leading CENP-E inhibitor, advances the study of centromere function and mitotic fidelity. This article uniquely connects recent mechanistic insights to practical assay design, offering cancer researchers a deeper, evidence-based perspective.

• 3-Bromopyruvate Induces Ferroptosis to Overcome Cetuximab Re

  2026-05-18

  This study demonstrates that co-treatment with 3-bromopyruvate (3-BP) and cetuximab can reverse intrinsic and acquired resistance in colorectal cancer cells by activating autophagy-dependent ferroptosis. The findings illuminate new therapeutic strategies for resistant colorectal cancer and highlight mechanistic insights into the role of FOXO3a signaling.

• Unlocking Caspase-8: Translational Strategy for Cell Death R

  2026-05-17

  Explore the mechanistic role of Caspase-8 in apoptosis and pyroptosis, recent breakthroughs in combinatorial cancer therapy, and how sensitive caspase activity measurement reshapes translational research. This article bridges the latest evidence with strategic guidance for deploying the Caspase-8 Fluorometric Assay Kit in advanced cell death models.

• AG-120 (Ivosidenib) in IDH1-Mutant AML: Workflows & Troubles

  2026-05-16

  AG-120 (Ivosidenib) empowers researchers with selective, high-efficacy inhibition of mutant IDH1, streamlining workflows for 2-hydroxyglutarate reduction and myeloid differentiation in AML models. This guide delivers stepwise protocols, advanced application insights, and troubleshooting strategies grounded in recent breakthroughs on metabolic rewiring and therapeutic resistance.

• hCG Modulates CXCL10 via H3K27 Methylation in Human Decidua

  2026-05-15

  This study uncovers how human chorionic gonadotropin (hCG) suppresses the chemokine CXCL10 in human decidual stromal cells by promoting H3K27me3 histone methylation at the CXCL10 promoter. The findings provide mechanistic insight into maternal-fetal immune regulation, with direct implications for epigenetic and inflammatory research.

• Iptacopan (LNP023): Optimizing Complement Pathway Inhibition

  2026-05-15

  Iptacopan (LNP023) empowers researchers with precise, oral alternative complement pathway inhibition, enabling robust modeling of hemolysis and inflammation across in vitro and in vivo systems. This guide translates clinical and mechanistic advances into actionable protocols, troubleshooting, and comparative assay strategies for next-generation complement research.

• Auranofin in Mechanotransduction: Redox, Autophagy, and Canc

  2026-05-14

  Explore how Auranofin, a potent thioredoxin reductase inhibitor, uniquely bridges oxidative stress modulation and mechanotransduction biology for advanced cancer research. This article presents new insights and protocols not covered in existing guides.

• GPR35-KLF5 Circuitry in Epithelial Repair: Insights from DSS

  2026-05-14

  This study delineates a novel GPR35-KLF5 signaling circuit that enables intestinal epithelial cells to sense and repair mucosal damage by decoding tryptophan metabolite signals. Using a dextran sulfate sodium salt (DSS)-induced mouse model of colitis, the authors clarify how disrupted metabolic sensing impairs repair, offering mechanistic targets for ulcerative colitis intervention.

• S-Adenosylmethionine (SAM): Precision Methylation in CNS Res

  2026-05-13

  Explore the multifaceted roles of S-adenosylmethionine (SAM) in CNS methylation and neurological disorder research. This article integrates technical assay guidance with new insights on methylation mechanisms, providing a distinct, evidence-driven analysis for advanced CNS applications.

• Mechanisms of Cell Death in Heart Disease: Implications for

  2026-05-13

  This review delineates how both apoptosis and necrosis—long seen as distinct—share regulatory machinery in cardiac pathology. It highlights the paradigm shift toward recognizing programmed necrosis and its disease relevance, suggesting opportunities for targeted intervention in heart failure and myocardial infarction.

• Efficient Purification of Recombinant Annexin V: Method and

  2026-05-12

  This article reviews the efficient method for recombinant annexin V purification described by Burger et al., highlighting the use of calcium-mediated binding to liposomes and mild cell lysis to achieve high-purity protein suitable for structural and functional studies. The protocol addresses longstanding challenges in co-purification artifacts and supports advanced biophysical analyses, with direct implications for research requiring stringent nucleic acid removal.

• Molidustat (BAY85-3934): Applied HIF Stabilization for Renal

  2026-05-12

  Molidustat (BAY85-3934) empowers researchers to model erythropoietin stimulation and hypoxia-inducible factor stabilization with unprecedented precision, directly impacting chronic kidney disease anemia research. This guide translates latest mechanistic insights and publication-backed protocols into actionable workflows, troubleshooting, and optimization strategies.

• Flavopiridol (L868275): Verified Benchmarks in Cancer Resear

  2026-05-11

  Flavopiridol (L868275) is a potent, selective pan-CDK inhibitor used extensively as a cell cycle arrest agent in cancer research. This article aggregates atomic, verifiable evidence on its mechanism, benchmarks, and workflow integration. Cited data highlight its efficacy in inhibiting CDKs, driving apoptosis, and enabling translational protocols.

• SM-164: Bivalent Smac Mimetic Empowering Apoptosis Assays

  2026-05-11

  SM-164, a high-affinity bivalent Smac mimetic from APExBIO, revolutionizes apoptosis induction in cancer research through rapid cIAP-1/2 and XIAP antagonism and robust TNFα-dependent cell death. Discover advanced workflows, protocol optimizations, and troubleshooting strategies to maximize assay sensitivity and reproducibility.

8602 records 14/574 page Previous Next First page 上5页 1112131415 下5页 Last page